ARTH - cheapest medical device company James Sulat (Momenta board of director) took a position as BOD member in ARTH. ARTH is developing an interesting device - best in class...i.e. synthetic biology at works...took a position a few weeks back,
Next Generation Medical Technology AC5™ stops bleeding promptly. Unlike many competitive products, it conforms to irregular wound geometry, allows for normal healing, and helps maintain a clear field of vision
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.